News & Events

Neil Hunter, a professor in the Department of Microbiology and Molecular Genetics and an Investigator with the Howard Hughes Medical Institute, has been elected as a Fellow of The Royal Society in London.

This prestigious appointment, announced May 20, was offered to only 70 scientists across the world.

“I’m thrilled and surprised,” said Hunter. “The acknowledgment means a great deal to me, because it’s an election by some of the best scientists in the world.”

When drug breakthroughs happen, the medical community rejoices. But some people can be left behind. Case in point: Rapamycin. Now a UC Davis professor is investigating how to bring back the benefits of a revolutionary drug to the people who were there from the beginning.

Spring began just two months ago, and already here in Davis it’s starting to feel like summer. There’s just about a month of the quarter left, during which our students will be preparing for final exams and then, for many, commencement. There’s still much to do between then and now, but the excitement of graduation season is already being felt in our classrooms, labs and across campus.

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea. But sometimes it triggers severe, even fatal disease by chewing ulcers in the colon, liquefying parts of the liver and invading the brain and lungs.

It is with great sadness that I am announcing a significant reduction in services to our students provided by the college’s Educational Enrichment and Outreach Programs (EEOP).